An independent ethics panel in the UK has concluded that genome editing to influence the characteristics of a future person could be “morally permissible”.
Cancer patients should have access to genetic testing to better tailor treatment for their disease and increase the likelihood of achieving the very best outcomes, concludes a new report by Chief Medical Officer Dame Sally Davies on genomics and its potential for NHS care.